Related Experiment Video

Updated: May 25, 2026

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

[Surgical therapy for ischemic cardiomyopathy]

Yoshitaka Ikeda1, Hiroshi Kurazumi, Masafumi Sato

  • 1Department of Surgery and Clinical Science, Division of Cardiac Surgery, Yamaguchi University School of Medicine, Ube, Japan.

Kyobu Geka. the Japanese Journal of Thoracic Surgery
|February 9, 2012
PubMed

Insights

Surgical ventricular restoration (SVR) combined with coronary artery bypass grafting (CABG) improved cardiac symptoms and ventricular function in patients with ischemic cardiomyopathy. This combination therapy offers better outcomes than CABG alone for specific patient groups.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Heart Failure Management

Context:

  • Ischemic cardiomyopathy (ICM) presents a significant challenge in heart failure treatment.
  • The efficacy of surgical ventricular restoration (SVR) combined with coronary artery bypass grafting (CABG) remains debated.
  • Previous trials like STICH have yielded mixed results regarding the benefits of adding SVR to CABG.

Purpose:

  • To investigate the efficacy of combining CABG with SVR for patients suffering from ICM.
  • To evaluate the impact of SVR on symptom relief, left ventricular function, and long-term survival in ICM patients.

Summary:

  • A retrospective study of 24 ICM patients undergoing CABG with or without SVR was conducted.
  • Patients receiving CABG with SVR showed significant relief in cardiac symptoms and reduction in left ventricular end-systolic volume index (LVESVI).
  • SVR demonstrated particular benefit in patients with smaller left ventricular end-diastolic dimensions (LVDd < 60 mm), improving symptoms and function.

Impact:

  • SVR, when added to CABG, offers significant symptomatic relief and functional improvement in select ICM patients, especially those with dilated cardiomyopathy.
  • The findings suggest SVR can enhance long-term survival beyond what CABG alone provides.
  • This study highlights the potential of SVR as a valuable adjunct therapy for specific ICM patient populations.
Abstract

More Related Videos

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System08:01

Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System

Published on: June 11, 2020

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...